Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity
Comparing SARS-CoV-2 infection-induced gene expression signatures to drug treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose existing drugs against SARS-CoV-2. The general hypothesis of signature-based drug repurposing is that drugs with inverse similarity to...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
April 11, 2022
|
| In: |
PLoS Computational Biology
Year: 2022, Jahrgang: 18, Heft: 4, Pages: 1-20 |
| ISSN: | 1553-7358 |
| DOI: | 10.1371/journal.pcbi.1010021 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1371/journal.pcbi.1010021 Verlag, kostenfrei, Volltext: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1010021 |
| Verfasserangaben: | Szilvia Barsi, Henrietta Papp, Alberto Valdeolivas, Dániel J. Tóth, Anett Kuczmog, Mónika Madai, László Hunyady, Péter Várnai, Julio Saez-Rodriguez, Ferenc Jakab, Bence Szalai |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1823261604 | ||
| 003 | DE-627 | ||
| 005 | 20231107083714.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221123s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1371/journal.pcbi.1010021 |2 doi | |
| 035 | |a (DE-627)1823261604 | ||
| 035 | |a (DE-599)KXP1823261604 | ||
| 035 | |a (OCoLC)1361670532 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Barsi, Szilvia |e VerfasserIn |0 (DE-588)1308883587 |0 (DE-627)1869493869 |4 aut | |
| 245 | 1 | 0 | |a Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity |c Szilvia Barsi, Henrietta Papp, Alberto Valdeolivas, Dániel J. Tóth, Anett Kuczmog, Mónika Madai, László Hunyady, Péter Várnai, Julio Saez-Rodriguez, Ferenc Jakab, Bence Szalai |
| 264 | 1 | |c April 11, 2022 | |
| 300 | |b Illustrationen | ||
| 300 | |a 20 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.11.2023 | ||
| 520 | |a Comparing SARS-CoV-2 infection-induced gene expression signatures to drug treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose existing drugs against SARS-CoV-2. The general hypothesis of signature-based drug repurposing is that drugs with inverse similarity to a disease signature can reverse disease phenotype and thus be effective against it. However, in the case of viral infection diseases, like SARS-CoV-2, infected cells also activate adaptive, antiviral pathways, so that the relationship between effective drug and disease signature can be more ambiguous. To address this question, we analysed gene expression data from in vitro SARS-CoV-2 infected cell lines, and gene expression signatures of drugs showing anti-SARS-CoV-2 activity. ... | ||
| 650 | 4 | |a Antivirals | |
| 650 | 4 | |a Cell membranes | |
| 650 | 4 | |a Chlorpromazine | |
| 650 | 4 | |a Cholesterol | |
| 650 | 4 | |a Drug therapy | |
| 650 | 4 | |a Gene expression | |
| 650 | 4 | |a SARS CoV 2 | |
| 650 | 4 | |a Transcription factors | |
| 700 | 1 | |a Papp, Henrietta |e VerfasserIn |4 aut | |
| 700 | 1 | |a Valdeolivas, Alberto |e VerfasserIn |0 (DE-588)121954048X |0 (DE-627)1735483141 |4 aut | |
| 700 | 1 | |a Tóth, Dániel J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kuczmog, Anett |e VerfasserIn |4 aut | |
| 700 | 1 | |a Madai, Mónika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hunyady, László |e VerfasserIn |4 aut | |
| 700 | 1 | |a Várnai, Péter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sáez Rodríguez, Julio |d 1978- |e VerfasserIn |0 (DE-588)133764362 |0 (DE-627)555766632 |0 (DE-576)300083114 |4 aut | |
| 700 | 1 | |a Jakab, Ferenc |e VerfasserIn |4 aut | |
| 700 | 1 | |a Szalai, Bence |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a Public Library of Science |t PLoS Computational Biology |d San Francisco, Calif. : Public Library of Science, 2005 |g 18(2022), 4, Artikel-ID e1010021, Seite 1-20 |h Online-Ressource |w (DE-627)491436017 |w (DE-600)2193340-6 |w (DE-576)273890492 |x 1553-7358 |7 nnas |
| 773 | 1 | 8 | |g volume:18 |g year:2022 |g number:4 |g elocationid:e1010021 |g pages:1-20 |g extent:20 |a Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity |
| 856 | 4 | 0 | |u https://doi.org/10.1371/journal.pcbi.1010021 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1010021 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20221123 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 133764362 |a Sáez Rodríguez, Julio |m 133764362:Sáez Rodríguez, Julio |d 910000 |d 912900 |e 910000PS133764362 |e 912900PS133764362 |k 0/910000/ |k 1/910000/912900/ |p 9 | ||
| 998 | |g 121954048X |a Valdeolivas, Alberto |m 121954048X:Valdeolivas, Alberto |d 910000 |d 950000 |d 950950 |e 910000PV121954048X |e 950000PV121954048X |e 950950PV121954048X |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950950/ |p 3 | ||
| 999 | |a KXP-PPN1823261604 |e 4218562393 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"April 11, 2022","dateIssuedKey":"2022"}],"physDesc":[{"noteIll":"Illustrationen","extent":"20 S."}],"recId":"1823261604","id":{"doi":["10.1371/journal.pcbi.1010021"],"eki":["1823261604"]},"person":[{"family":"Barsi","display":"Barsi, Szilvia","given":"Szilvia","role":"aut"},{"role":"aut","given":"Henrietta","family":"Papp","display":"Papp, Henrietta"},{"given":"Alberto","role":"aut","family":"Valdeolivas","display":"Valdeolivas, Alberto"},{"role":"aut","given":"Dániel J.","family":"Tóth","display":"Tóth, Dániel J."},{"role":"aut","given":"Anett","display":"Kuczmog, Anett","family":"Kuczmog"},{"family":"Madai","display":"Madai, Mónika","role":"aut","given":"Mónika"},{"display":"Hunyady, László","family":"Hunyady","given":"László","role":"aut"},{"display":"Várnai, Péter","family":"Várnai","given":"Péter","role":"aut"},{"role":"aut","given":"Julio","display":"Sáez Rodríguez, Julio","family":"Sáez Rodríguez"},{"display":"Jakab, Ferenc","family":"Jakab","role":"aut","given":"Ferenc"},{"family":"Szalai","display":"Szalai, Bence","given":"Bence","role":"aut"}],"name":{"displayForm":["Szilvia Barsi, Henrietta Papp, Alberto Valdeolivas, Dániel J. Tóth, Anett Kuczmog, Mónika Madai, László Hunyady, Péter Várnai, Julio Saez-Rodriguez, Ferenc Jakab, Bence Szalai"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity","title_sort":"Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity"}],"relHost":[{"origin":[{"publisherPlace":"San Francisco, Calif.","dateIssuedDisp":"2005-","dateIssuedKey":"2005","publisher":"Public Library of Science"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"491436017","pubHistory":["1.2005 -"],"id":{"issn":["1553-7358"],"zdb":["2193340-6"],"eki":["491436017"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"name":{"displayForm":["publ. by the Public Library of Science (PLoS) in association with the International Society for Computational Biology (ISCB)"]},"part":{"pages":"1-20","text":"18(2022), 4, Artikel-ID e1010021, Seite 1-20","extent":"20","year":"2022","volume":"18","issue":"4"},"language":["eng"],"disp":"Public Library of SciencePLoS Computational Biology","title":[{"title_sort":"PLoS Computational Biology","title":"PLoS Computational Biology","subtitle":"a new community journal"}],"note":["Gesehen am 23. November 2020"],"corporate":[{"role":"aut","display":"Public Library of Science"}]}],"note":["Gesehen am 07.11.2023"]} | ||
| SRT | |a BARSISZILVCOMPUTATIO1120 | ||